PHILLIPS BARCLAY A
Insider CIK 1265801 · NVAX SVP, Chief Financial Officer, Director · MITI SVP, CFO · IMUX Director · GTHX SVP & Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMUX IMMUNIC, INC. | A Award deriv | 2026-07-05 | 2026-07-07 | 25,370 | — | $0 | 25,370 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2026-06-29 | 2026-06-29 | 25,370 | — | $0 | 25,370 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2025-06-05 | 2025-06-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2024-06-11 | 2024-06-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 19,973 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 9,986 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2024-03-04 | 2024-03-06 | 64,959 | — | $0 | 64,959 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 15,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2023-06-28 | 2023-06-29 | 16,000 | — | $0 | 16,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2022-06-15 | 2022-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2020-07-02 | 2020-07-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2019-11-18 | 2019-11-19 | 29,959 | — | $0 | 29,959 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2019-01-02 | 2019-01-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | M Exercise deriv | 2018-11-15 | 2018-11-16 | 5,000 | — | $0 | 95,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 5,000 | $39.92 | $199.6K | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | M Exercise | 2018-11-15 | 2018-11-16 | 5,000 | $19.46 | $97.3K | 5,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2017-12-06 | 2017-12-06 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2017-07-31 | 2017-08-01 | 2,057 | $0.89 | $1.8K | 38,669 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2017-05-11 | 2017-05-11 | 25,000 | $0.84 | $21.0K | 36,612 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2017-01-31 | 2017-02-02 | 1,633 | $1.12 | $1.8K | 11,612 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2016-11-14 | 2016-11-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2016-11-14 | 2016-11-16 | 125,000 | — | $0 | 125,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2016-07-31 | 2016-08-02 | 422 | $4.29 | $1.8K | 9,979 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2016-03-15 | 2016-03-17 | 225,000 | — | $0 | 225,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2016-01-31 | 2016-02-01 | 405 | $4.38 | $1.8K | 9,557 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2015-08-20 | 2015-08-21 | 10,000 | $12.81 | $128.1K | 9,152 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2015-08-19 | 2015-08-21 | 18,656 | $13.20 | $246.3K | 19,152 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2015-07-31 | 2015-08-04 | 764 | $2.28 | $1.7K | 37,808 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2015-03-05 | 2015-03-09 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2015-01-31 | 2015-02-03 | 8,388 | $2.28 | $19.1K | 37,044 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-10-03 | 2014-10-06 | 5,000 | $4.11 | $20.6K | 28,656 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-07-31 | 2014-08-04 | 8,788 | $2.28 | $20.0K | 23,656 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-03-25 | 2014-03-25 | 5,000 | $4.25 | $21.3K | 14,868 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-03-25 | 2014-03-25 | 5,000 | $4.25 | $21.3K | 14,868 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2014-03-06 | 2014-03-07 | 150,000 | — | $0 | 450,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-01-31 | 2014-02-04 | 9,868 | $2.29 | $22.6K | 9,868 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2013-06-12 | 2013-07-03 | 50,000 | $1.90 | $95.0K | 200,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2013-06-12 | 2013-07-05 | 0 | — | $0 | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 112,500 | $5.17 | $581.6K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 235,796 | $4.77 | $1.12M | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 135,000 | $2.92 | $394.2K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 37,500 | $7.84 | $294.0K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 21,875 | $7.84 | $171.5K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 64,204 | $4.77 | $306.3K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 2,500 | $4.37 | $10.9K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 35,000 | $4.37 | $152.9K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 3,333 | $2.54 | $8.5K | 0 | SEC↗ |
| MITI MICROMET, INC. | U Tender | 2012-03-02 | 2012-03-06 | 1,483 | $11.00 | $16.3K | 0 | SEC↗ |